Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

In Silico Models for Nanomedicine: Recent Developments

Author(s): Pietro Mascheroni and Bernhard Aribo Schrefler*

Volume 25, Issue 34, 2018

Page: [4192 - 4207] Pages: 16

DOI: 10.2174/0929867324666170417120725

Price: $65

Abstract

Nanomedicine is a recent promising setting for the advancement of current medical therapies, in particular for cancer. Nanoparticle-mediated therapies are aimed to tackle extremely complex phenomena, involving different biochemical, mechanical and biophysical factors. Computational models can contribute to medical research by helping the understanding of biological mechanisms and by providing quantitative analyses. In this work, we report on computational models that address four main issues related to the use of nanoparticles in anti-cancer therapies, namely the delivery of nanoparticles, their uptake by cells, the release of drugs from nano-platforms and nanoparticle-based therapeutics. In silico approaches constitute a valuable tool to aid clinical studies, to guide the rational design of new nanoparticle formulations and to identify the optimal strategies for existing treatments.

Keywords: Nanoparticles, nanoparticle delivery, uptake, drug release, therapeutic effects, mathematical and computational models.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy